![Impact of Double- or Triple-Hit Pathology on Rates and Durability of Radiation Therapy Response Among Patients With Relapsed or Refractory Large B-Cell Lymphoma - Practical Radiation Oncology Impact of Double- or Triple-Hit Pathology on Rates and Durability of Radiation Therapy Response Among Patients With Relapsed or Refractory Large B-Cell Lymphoma - Practical Radiation Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bdd30c31-c0e4-4f43-ba98-d7181fa1720b/gr1.jpg)
Impact of Double- or Triple-Hit Pathology on Rates and Durability of Radiation Therapy Response Among Patients With Relapsed or Refractory Large B-Cell Lymphoma - Practical Radiation Oncology
![Overall survival curve of patients with double-hit lymphoma (DHL) shows... | Download Scientific Diagram Overall survival curve of patients with double-hit lymphoma (DHL) shows... | Download Scientific Diagram](https://www.researchgate.net/profile/Mustafa-Benekli/publication/51976403/figure/fig4/AS:277254245502982@1443113971262/Overall-survival-curve-of-patients-with-double-hit-lymphoma-DHL-shows-inferior-survival_Q640.jpg)
Overall survival curve of patients with double-hit lymphoma (DHL) shows... | Download Scientific Diagram
![MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas | Modern Pathology MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41379-018-0067-x/MediaObjects/41379_2018_67_Fig1_HTML.jpg)
MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas | Modern Pathology
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients | Haematologica
![Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma | Diagnostic Pathology | Full Text Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma | Diagnostic Pathology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13000-019-0856-7/MediaObjects/13000_2019_856_Fig3_HTML.png)
Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma | Diagnostic Pathology | Full Text
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica
![Kaplan-Meier curves of progression-free survival and overall survival.... | Download Scientific Diagram Kaplan-Meier curves of progression-free survival and overall survival.... | Download Scientific Diagram](https://www.researchgate.net/profile/Noriyoshi-Iriyama/publication/282046248/figure/fig1/AS:499557352079360@1496115162692/Kaplan-Meier-curves-of-progression-free-survival-and-overall-survival-Progression-free.png)
Kaplan-Meier curves of progression-free survival and overall survival.... | Download Scientific Diagram
![Progression-free survival (PFS) curves (A) and overall survival (OS)... | Download Scientific Diagram Progression-free survival (PFS) curves (A) and overall survival (OS)... | Download Scientific Diagram](https://www.researchgate.net/profile/Noriyoshi-Iriyama/publication/301288967/figure/fig2/AS:499556519342080@1496114963286/Progression-free-survival-PFS-curves-A-and-overall-survival-OS-curves-B-of-the.png)
Progression-free survival (PFS) curves (A) and overall survival (OS)... | Download Scientific Diagram
![Double or triple-expressor lymphomas: prognostic impact of immunohistochemistry in patients with diffuse large B-cell lymphoma | Hematology, Transfusion and Cell Therapy Double or triple-expressor lymphomas: prognostic impact of immunohistochemistry in patients with diffuse large B-cell lymphoma | Hematology, Transfusion and Cell Therapy](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2531137919300926:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w92xcqUtYYCc6yiYRjTD2AR3zJSEmH4GGT8A27de8H5QqAdccHlDwud9PYwTAyLTEDvWpYXi5qL2+GhZL4f2+EJIdDjTtZXiAStX7HJEFHWpi8FM51QqKF+cYJF28SY5xxB05TTuPmfXavWwyVonIlRKlNBrzfzdPzQ+kkX+VaOgnDf0+z5YuqaUBPdRZKyRnQxCknoOGWOqGka1XqCHNLYNuxNgvLc5aDQJBqGt92GnXvip47o1SeVh3JNTtAvXYAhvFzyQjZNZgNUoOnv41AxEd4fX2arWbl/5tsTtAR9B+)
Double or triple-expressor lymphomas: prognostic impact of immunohistochemistry in patients with diffuse large B-cell lymphoma | Hematology, Transfusion and Cell Therapy
![Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma | Modern Pathology Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.2017.93/MediaObjects/41379_2017_Article_BFmodpathol201793_Fig3_HTML.jpg)
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma | Modern Pathology
![DOUBLE-HIT AND TRIPLE-HIT LYMPHOMAS: TREATMENT AND CLINICAL OUTCOME.... EHA Library. Martínez Serra L. May 18 2017; 182440 DOUBLE-HIT AND TRIPLE-HIT LYMPHOMAS: TREATMENT AND CLINICAL OUTCOME.... EHA Library. Martínez Serra L. May 18 2017; 182440](http://www.multiwebcast.com/image/abstract/eha_2017/EHA-3998.jpg)
DOUBLE-HIT AND TRIPLE-HIT LYMPHOMAS: TREATMENT AND CLINICAL OUTCOME.... EHA Library. Martínez Serra L. May 18 2017; 182440
![Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. - Abstract - Europe PMC Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5455688/bin/JCO.2016.68.2740t3.jpg)
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. - Abstract - Europe PMC
![Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma | Leukemia Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-018-0320-9/MediaObjects/41375_2018_320_Fig1_HTML.png)
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma | Leukemia
![Cureus | Double-Expressor Phenotype (BCL-2/c-MYC Co-expression) of Diffuse Large B-Cell Lymphoma and Its Clinicopathological Correlation Cureus | Double-Expressor Phenotype (BCL-2/c-MYC Co-expression) of Diffuse Large B-Cell Lymphoma and Its Clinicopathological Correlation](https://assets.cureus.com/uploads/figure/file/185540/7021f4d0626311eb98bafb0a14d164b4-FIG-1-DE-SHarp.png)
Cureus | Double-Expressor Phenotype (BCL-2/c-MYC Co-expression) of Diffuse Large B-Cell Lymphoma and Its Clinicopathological Correlation
![Overall survival comparison based on (a) BCL2 and BCL6 rearrangement vs... | Download Scientific Diagram Overall survival comparison based on (a) BCL2 and BCL6 rearrangement vs... | Download Scientific Diagram](https://www.researchgate.net/publication/318907303/figure/fig3/AS:667765232898049@1536219046227/Overall-survival-comparison-based-on-a-BCL2-and-BCL6-rearrangement-vs-extra-copies-in.png)
Overall survival comparison based on (a) BCL2 and BCL6 rearrangement vs... | Download Scientific Diagram
![MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas | Modern Pathology MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41379-018-0067-x/MediaObjects/41379_2018_67_Fig3_HTML.jpg)